XCath Chief Executive Officer Eduardo Fonseca was formerly an Investment Director in the Crescent Group Investments Team and the Chief Corporate Development Officer of Gulftainer USA. In addition to leading the strategic direction of XCath, he is a member of the Board of Directors for Endoquest Robotics Inc., and HomeWork Mx. Prior to joining Crescent Group, Fonseca was the first Panamanian Ambassador to the United Arab Emirates and the first Ambassador to Saudi Arabia. He holds an MBA from INSEAD, a BS in Commerce from Santa Clara University, and is a member of the National Association of Corporate Directors (NACD.)
Access to minimally invasive treatment of complex vascular conditions is still limited worldwide. Bringing endovascular robots to ORs and healthcare facilities worldwide is key to improving stroke prevention and treatment and reducing the morbidity and financial burden of stroke and other life-threatening vascular conditions.